YARMOUTH, Maine, April 17, 2016 -- Stem cell therapy offers pets and their owners an alternative to invasive surgery, reports Yarmouth Veterinary Center. Pets no longer have to undergo painful, destructive steroid injections or undertake invasive surgery for particular joint conditions and other issues. An effective breakthrough treatment, stem cell therapy, is available for pets at Yarmouth Veterinary Center. This animal hospital is one of only two veterinary clinics in all of Maine to offer this revolutionary alternative.
Surgery is known to be painful and possibly require a considerable period of recovery or even rehabilitation. Steroid injections are meant as a stopgap, offering short-term relief but contributing to the deterioration of the area when used long-term. Stem cell therapy offers an alternative to these common approaches.
As reported in numerous studies, stem cell therapy is a powerful anti-inflammatory and regenerative medicine. It is safe for people and animals. Stem cell therapy is used in pets to repair and even regenerate a particular area without surgery or significant downtime. Response rates vary but based on thousands of veterinary patients, and significant studies, over 50% of patients have had good to excellent results. The type, stage and expected progress of a pet’s specific concern should be considered when evaluating stem cell therapy response. Arthritis and other chronic or progressive problems may require more than one treatment of stem cell therapy or a combination of therapies for best results.
“We are pleased to provide pets and their owners with this effective alternative,” said Dr. Louise LeBoeuf, DVM. “From my previous experience, many pet owners have delayed needed surgery due to cost, fear and the potential of a long recovery period. Owners turn to steroid injections and pain medications to help pets feel some relief. It is proven that reliance on steroids and medications should not be a part of pet owner’s long-term strategy. With stem cell therapy, pets can experience better range of motion and improved joint health without medications, unnecessary pain or surgery. We are proud to offer this revolutionary treatment option as a natural and effective alternative.”
Dr. Louise LeBoeuf, DVM, is one of the practicing veterinarians Yarmouth Veterinary Center, serving residents of Yarmouth, Cumberland, Falmouth, Portland, Freeport, Pownal, Brunswick and the surrounding communities since 2000 at its current site. Patients benefit from a full-service animal hospital with a personalized approach to veterinary care. Yarmouth veterinarians and staff offer medical, surgical and dental care, diagnostic testing, house calls, boarding, nutritional and behavioral consultations, an in-house pharmacy and an online pet health library. Patients benefit from compassionate treatment and the latest approaches in veterinary medicine at Yarmouth Veterinary Center.
Call (207) 846-6515 to schedule an appointment to discuss stem cell therapy as a treatment option for a pet or visit http://yarmouthvetcenter.com/ for more details.
Yarmouth Veterinary Center, (207) 846-6515


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Instagram Outage Disrupts Thousands of U.S. Users
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



